BELMONT, MASSACHUSETTS - The recently released Stanford University 2022 AI Index Report argues that "2021 was the year that artificial intelligence (AI) went from an emerging technology to a mature technology... that has real-world impact, both positive and negative." The fifth installment of the index measures the growing impact of AI in several ways: Private investment in AI more than doubled in 2021; the cost to train an image classification has decreased by 63.6 percent and training times have improved by 94.4 percent since 2018; the number of AI patents filed in 2021 was more than 30 times higher than in 2015; and, since 2015, 18 times more AI-related bills were passed into law in the legislatures of 25 countries around the world. However, there is very little in the report about successful deployments of AI, and nothing regarding the progress of AI in healthcare, a field that has been considered a prime candidate for demonstrating AI's real-world impact. The first study to demonstrate AI's potential in detecting disease from medical images was released in 2016. Describing the application of deep learning (DL) to screening for diabetic retinopathy, this study by Google researchers was selected by the editors of the Journal of the American Medical Association as being one of the top 10 most influential papers of the decade. Also in 2016, Turing-award winner Geoffrey Hinton, widely considered to be the "godfather of deep learning," suggested that the training of radiologists should be abolished, as it was "completely obvious" to him that "within five years, deep learning is going to do better."

The global pandemic has heightened our understanding and sense of importance of our own health and the fragility of healthcare systems around the world. We've all come to realize how archaic many of our health processes are, and that, if we really want to, we can move at lightning speed. This is already leading to a massive acceleration in both the investment and application of artificial intelligence in the health and medical ecosystems. Modern medicine in the 20th century benefited from unprecedented scientific breakthroughs, resulting in improvements in every aspect of healthcare. As a result, human life expectancy increased from 31 years in 1900 to 72 years in 2017.

Healthcare is becoming both increasingly data driven and automated. Drawing on a largescale review of artificial intelligence developments in the field of mental health and wellbeing, Elizabeth Morrow, Teodor Zidaru-Bărbulescu and Rich Stockley, find that opportunities for patients to influence and inform these future technologies are often lacking, which in turn may heighten disillusionment and lack of trust in them. As such, they propose four priorities for new data driven technologies to ensure they are ethical, effective and equitable for diverse patient groups. As the pandemic has sadly made clear, health policymakers and practitioners often make rapid, complex, life and death decisions. It has also demonstrated the pivotal role of technology in aiding such decisions in infection control and vaccine development.

Future AI systems are ramped up into medical research and evolving the best practices in the healthcare sector. With constant improvement in a different paradigm, patient-centered service is a leading focus. This aims for improving between good health care and the healthcare that people actually receive. Using advanced human-generated data devices, multiple office visits for checkups, and routine treatment are replaced with remote monitoring. Providers can save time and increase the accuracy of their diagnoses when this tracking is combined with online consultations, driven by AI.

AI is an enabler in transforming healthcare delivery in terms of treatment modalities and their outcomes, electronic health records-based prediction, diagnosis and prognosis and precision medicine. This course will introduce you to the cutting edge advances in AI concerning healthcare by exploiting deep learning architectures. The course aims to provide students from diverse backgrounds with both conceptual understanding and technical grounding of leading research on AI in healthcare.

Israeli AI healthcare analytics platform CLEW today announced that it has successfully raised $10 million in a Series B financing round led by Pitango Venture Capital and with the participation of all existing investors with additional strategic participation from Relyens - a European mutual group insurance and risk manager specializing in the healthcare industry. Pierre-Yves Antier, Head of Strategy, Innovation and Transformation of Relyens will join CLEW's Board of Directors. Clew has raised over $20 million to date. CLEW's healthcare analytics platform delivers improved clinical and operational outcomes by predicting life-threatening complications and detects deviations from the optimal clinical path. The latest financing will be used to commercialize CLEW's platform in the TeleICU and critical care markets. .

The AI LA Community and Innovate Pasadena present to you an evening to connect with brilliant minds to discuss how artificial intelligence is impacting healthcare. We will dive into therapeutics, diagnostics, information systems, and digital health. This panel discussion is part of our inaugural Life Summit part of Connect Week, where we invite health system leaders to workshop their internal problems using a design thinking process. By participating at the event, you grant the AI LA Community, Inc permission to capture photo/video of the event. You can find the exact legal terms on our Event Recording Policy.

Just like every other industry, the healthcare industry is taking advantage of the use of new technologies such as artificial intelligence. In 2016, it was reported that 86% of organisations were using artificial intelligence in healthcare. Furthermore, spending on AI healthcare in organisations will increase to an average of $54 million by 2020. So, where are you most likely to see artificial intelligence in healthcare? Here are ten of the most popular uses for AI healthcare and where it has the potential to change the industry.

Chinese tech giant Tencent's first attempt in AI healthcare was the Miying platform, which has been a point of pride for CEO Huateng Ma since its 2017 launch. Supported by AI-powered medical imaging technologies, Miying assists doctors with the screening of esophageal cancer, pulmonary nodules, cervical cancer, etc. The platform has been well received in the AI and medical communities, with a fast-expanding market in Chinese top-tier AAA hospitals. At the recent International Congress of Parkinson's Disease and Movement Disorders in Hong Kong, Tencent unveiled its second layout in AI healthcare: Medical AI Lab. The lab team includes experts in machine learning, computational vision, video analytics, augmented reality (AR), natural language understanding (NLU), etc. Tencent Medical AI Lab is the latest in the company's continuing efforts on AI to Business marketing.